Skip to main content
OpenTrials
Completed

NCT Number: NCT06982560

Electrical Cardiometry in Management of Acute Heart Failure

The goal of this clinical trial is to assess if electrical cardiometry (EC) could help in managing acute heart failure (AHF). The main questions it aims to answer are:

1. Is there effect of use of cardiometry on rate of use of vasopressors, vasodilators and inotropes? 2. is there effect of use of cardiometry on mortality and hospital length of stay?

Researchers compared cardiometry to traditional methods like clinical examination, lung ultrasound and inferior vena cava.

Participants were divided into two groups, one managed by cardiometry and the other by traditional methods, then followed till improvement or death and compared regarding use of medications, length of stay and mortality

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Heart Failure (AHF)

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alexandria University Hospitals

Alexandria, Alexandria Governorate, Egypt

About this study

The purpose of the research is to assess the role of electrical cardiometry in hemodynamic monitoring in studied cases with acute heart failure to guide treatment.

This is a prospective controlled research that involved fifty patients, diagnosed with acute heart failure and admitted to critical care units at Alexandria University Hospitals, patients were divided into 2 groups:

Group A: was assessed by traditional methods which include: clinical examination including chest auscultation and systolic blood pressure measurement, lung ultrasound and inferior vena cava assessment and managed according to the results of these parameters.

Group B: was assessed by electrical cardiometry parameters as cardiac output, thoracic fluid content (TFC) and systemic vascular resistance (SVR) and was managed as following: inotropes up and down titration according to cardiac output readings, use of vasopressors or vasodilators according to SVR readings, doses of diuretics were modified according to TFC readings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute heart failure

Exclusion criteria

  • pregnant females, atrial fibrillation, severe valvular diseases, skin lesions in thoracic area, large pleural effusion

Treatment and study plan

Electrical cardiometry

Device

use of cardiometry parameters as cardiac output, thoracic fluid content, systemic vascular resistance

traditonal methods

Other

clinical examination, lung ultrasound, inferior vena cava

Primary outcomes

  1. mortality and intensive care unit (ICU) length of stay

    Time frame: 7 days

    number of days in ICU and mortality in ICU

Secondary outcomes

  1. use of vasopressors, vasodilators, inotropes

    Time frame: 7 days

    number of patients who needed these medications

Sponsors and collaborators

Lead sponsor

Alexandria University

Other

Registry information

Official study title

Assessment and Management of Acute Heart Failure Patients Guided by Electrical Cardiometry

Acronym: EC/AHF

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
May 21, 2025
Registry last updated
May 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.